In a February 2024 article for Managed Health Care Executive 3 , Lassen states, Our chief concern with these drugs right now is how do we best manage the waste, because theres a real potential if people in real-world practice are not staying on these medications, then they are not going to do anything but promote cost and temporary weight loss, he says
It is the primary barrier between a clean solution and a contaminated one
It is not uncommon for adverse effects to cause a semaglutide patient to discontinue their medication, says the meta-analysis
Ultimately, informed collaboration with healthcare providers empowers individuals toward a balanced and liberated approach to their medication regimen
Yes, clinical evidence shows that semaglutide often improves liver enzyme levels in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
Paula Morris-Kaufman, of Cheshire, UK, used the drug to address weight gain following cancer treatments